Special dialysis filter for septic shock with kidney failure
Part of Infections, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether using a special filter (oXiris) during dialysis can better remove harmful toxins from the blood in people with septic shock and kidney failure, potentially helping them recover faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have septic shock: blood pressure stays low and you need medication to keep it up, even after receiving fluids.
- Your kidneys have failed to the point that you need a type of dialysis called CRRT.
- You are not having major bleeding, and you have no serious bleeding risk.
- You are not allergic to heparin or the filter materials.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks back at how a special kidney filter called oXiris helped patients in the ICU who had septic shock (a life-threatening blood infection) and kidney failure. Researchers want to understand if this filter improved survival and recovery compared to standard treatment.
This trial tests a special blood filter called Oxiris that may help remove toxins and inflammation from the blood in patients with septic shock. It aims to see if this treatment can improve outcomes for people who need kidney replacement therapy.
This study tests a special blood-filtering treatment (called Oxiris) for people with septic shock, a life-threatening condition where infection causes very low blood pressure. The goal is to see if this treatment can safely improve recovery. If you are already receiving CRRT, this may help your blood get cleaner and your pressure more stable.
This trial tests a special blood filtering device (OXiris) in patients with severe abdominal infections and septic shock. The filter may help remove harmful substances from the blood and support kidney function, potentially improving recovery.
This study tests a special filter (HA380 column) used during dialysis or ECMO to remove harmful substances from the blood. It is for critically ill patients with severe infection, injury, or breathing problems who also need kidney or lung support.
This study tests a blood-filtering treatment for people with septic shock, a severe infection that causes very low blood pressure. The treatment aims to remove harmful substances from the blood to help patients recover.
Hear when a new Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.